NCT06362161 Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
| NCT ID | NCT06362161 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Functional Neurological Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2025-07-18 |
| Primary Completion | 2028-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,100 participants in total. It began in 2025-07-18 with a primary completion date of 2028-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to help providers develop an interdisciplinary treatment pathway for functional neurological disorder (FND) at University of Alabama at Birmingham (UAB), and will involve psychiatry, speech therapy, physical therapy, and occupational therapy. The study will also help providers to evaluate the treatment pathway and publish results regarding the process and outcomes.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of FND * Can read and write English fluently * Referred to UAB outpatient treatment for FND in physical, occupational, or speech therapy * Referred to UAB outpatient treatment for FND in psychiatry * Referred to inpatient consult for FND at Children's of Alabama or UAB Hospital * Parent/guardian willing to participate in the study with a pediatric patient Exclusion Criteria: * Unable to read or write English fluently
Contact & Investigator
Aaron Fobian, PhD
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT06362161 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 89 Years, studying Functional Neurological Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06362161 currently recruiting?
Yes, NCT06362161 is actively recruiting participants. Contact the research team at afobian@uabmc.edu for enrollment information.
Where is the NCT06362161 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06362161 clinical trial?
NCT06362161 is sponsored by University of Alabama at Birmingham. The principal investigator is Aaron Fobian, PhD at University of Alabama at Birmingham. The trial plans to enroll 1,100 participants.